Correlation Between BRIM Biotechnology and Medeon Biodesign

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BRIM Biotechnology and Medeon Biodesign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRIM Biotechnology and Medeon Biodesign into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BRIM Biotechnology and Medeon Biodesign, you can compare the effects of market volatilities on BRIM Biotechnology and Medeon Biodesign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRIM Biotechnology with a short position of Medeon Biodesign. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRIM Biotechnology and Medeon Biodesign.

Diversification Opportunities for BRIM Biotechnology and Medeon Biodesign

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between BRIM and Medeon is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding BRIM Biotechnology and Medeon Biodesign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medeon Biodesign and BRIM Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRIM Biotechnology are associated (or correlated) with Medeon Biodesign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medeon Biodesign has no effect on the direction of BRIM Biotechnology i.e., BRIM Biotechnology and Medeon Biodesign go up and down completely randomly.

Pair Corralation between BRIM Biotechnology and Medeon Biodesign

Assuming the 90 days trading horizon BRIM Biotechnology is expected to under-perform the Medeon Biodesign. In addition to that, BRIM Biotechnology is 1.59 times more volatile than Medeon Biodesign. It trades about -0.19 of its total potential returns per unit of risk. Medeon Biodesign is currently generating about -0.3 per unit of volatility. If you would invest  4,680  in Medeon Biodesign on September 4, 2024 and sell it today you would lose (390.00) from holding Medeon Biodesign or give up 8.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BRIM Biotechnology  vs.  Medeon Biodesign

 Performance 
       Timeline  
BRIM Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Medeon Biodesign 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medeon Biodesign has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Medeon Biodesign is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

BRIM Biotechnology and Medeon Biodesign Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BRIM Biotechnology and Medeon Biodesign

The main advantage of trading using opposite BRIM Biotechnology and Medeon Biodesign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRIM Biotechnology position performs unexpectedly, Medeon Biodesign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medeon Biodesign will offset losses from the drop in Medeon Biodesign's long position.
The idea behind BRIM Biotechnology and Medeon Biodesign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities